Skip to content

A randomized controlled trial of sentinel lymph node tracing in endometrial cancer

A randomized controlled trial of sentinel lymph node tracing in endometrial cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042626
Enrollment
Unknown
Registered
2021-01-24
Start date
2021-02-01
Completion date
Unknown
Last updated
2021-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial carcinoma

Interventions

Group A:Intrauterine injection of indocyanine green
Group B:Transcervical injection of indocyanine green

Sponsors

Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who pathologically confirmed diagnosis of endometrial cancer without fertility requirements; 2. Patients who have not received radiotherapy, chemotherapy or other treatments before surgery; 3. Patients without severe underlying diseases who can tolerate surgical anesthesia; 4. The subject voluntarily participates in the study and signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with fertility requirements; 2. Patients with other types of malignant tumors; 3. Patients with other diseases can not tolerate surgery;

Design outcomes

Primary

MeasureTime frame
Detection rate of lymph node;Number of lymph nodes detected;the bilateral detection rate of SLN;accuracy rate of SLN;negative predictive value of SLN;

Countries

China

Contacts

Public ContactLi He

Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China

helisc@163.com+86 13881782966

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026